期刊文献+

肿瘤干细胞传统治疗抵抗与靶向治疗 被引量:5

Targeted Therapies and Resistance of Tumor Stem Cells to Traditional Therapies
下载PDF
导出
摘要 近年来,不断有资料表明,肿瘤干细胞和正常干细胞具有相似的性质。肿瘤干细胞导致肿瘤的发生、复发及转移。肿瘤干细胞对传统治疗方法的抵抗是肿瘤治疗失败的主要原因。同时,肿瘤干细胞位于特定的微环境中,肿瘤干细胞与微环境的相互作用显著影响肿瘤的进程。本文针对肿瘤干细胞及其微环境的靶向治疗做一综述,期望为肿瘤治疗带来新的思路。 Recent literature indicates that tumor stem cells (TSCs) have properties similar to normal stem cells. TSCs cause tumorigenesis, recurrence and metastasis. The resistance of TSCs to traditional thera- pies is the main cause of treatment failure. In addition, TSCs are located in the special microenvironment, and the interactions between TSCs and their microenvironment have a profound influence on the tumorigenic pro- cess. This review focuses on the microenvironment of TSCs and corresponding target therapies in an effort to provide new ideas for tumor therapies.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2009年第4期230-233,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30670798)~~
关键词 肿瘤干细胞 微环境 靶向治疗 Tumor stem cell Microenvironment Target therapy
  • 相关文献

参考文献18

  • 1Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature, 2001, 414(6859): 105-111.
  • 2Dormenberg VS, Donnenberg AD. Multiple drug resistance in cancer revisited:the cancer stem cell hypothesis[J].J Clin Pharmacol,2005, 45(8): 872-877.
  • 3Haraguchi N, Utsunomiya T, Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system[J]. Stem Cells, 2006, 24(3): 506-513.
  • 4Chang JC, LiX, Wong H, et al. Therapeutic resistance and tumor-initiation: Molecular pathways involved in breast cancer stem cell serf-renewal[J]. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part Ⅰ, 2007, 25: 528-540.
  • 5Phillips TM, McBride WH, Pajonk F. The response of CD24(-/ low)/CD44 + breast cancer-initiating cells to radiation[J]. J Natl Gancer Inst, 2006, 98(24): 1777-1785.
  • 6Woodward WA, Chen MS, Behbod F, et al. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells [J]. Proc Natl Acad Sci U S A, 2007, 104(2): 618-623.
  • 7Bao S, Wu Q,McLendon R E, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response[J]. Nature, 2006, 444(7120): 756-760.
  • 8Wicha MS,Liu S,Dontu G.Cancer stem cells: an old idea-a paradigm shift[J]. Cancer Res, 2006, 66(4): 1883-1890.
  • 9Fan X, Matsui W, Khaki L,et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain minors[J]. Cancer Res, 2006, 66(15): 7445-7452.
  • 10Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy[J]. J Natl Cancer Inst, 2008, 100(9): 672-679.

同被引文献47

  • 1郑玉军,张忠鲁.肿瘤的分子靶向治疗[J].辽宁中医药大学学报,2009,11(3):73-78. 被引量:2
  • 2车树圣,孟庆海,金澎,李洛,刘福生.脑胶质瘤干细胞的体外培养与生物学特性观察[J].山东医药,2007,47(15):1-2. 被引量:4
  • 3药立波.医学分子生物学.人民卫生出版社,2005(2):161-164.
  • 4Morett L, Bottinob C, Ferlazzo G, et al. Surface receptors and functional interations of human natueal killer cells: from bench to the clinic[J]. Cell Mol Life Sci, 2003, 60(10): 2139-2146.
  • 5Reardon DA. Wen PY. Therapeutic advances in the treatment of glioblastoma:rationale and potential role of targeted agents[J]. Oncologist, 2006, 11(2): 152-164.
  • 6Teshima T, Hill GR, Pan L, et al. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation[J].J Clin Invest, 1999, 104(3): 317-325.
  • 7Giver CR, Montes RO, Mittelstaedt S, et al. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cell while preserving graft-versus-leukemia effects[J]. Biol Blood Marrow Transplant, 2003, 9(10): 616-632.
  • 8Ma T,Grayson WL,Frohlich M,et al.Hypoxia and stem cell-based engineering of mesenchymal tissues[J].Biotechnol Prog,2009,25(1):32-42.
  • 9Guzman ML,Rossi RM,Neelakantan S,et al.An orally bioavailable parthenolide analog selectivdy eradicates acute myelogenous leukemia stem and progenitor cells[J].Blood,2007,110(13):4427-4435.
  • 10Kawasaki BT,Hurt EM,Kalathur M,et al.Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells:An integrated molecular profiling approach[J].Prostate,2009,69(8):827-837.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部